Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers

M. Čihák, H. Horáková, M. Vyhnálek, K. Veverová, V. Matušková, J. Laczó, J. Hort, T. Nikolai

. 2024 ; 39 (7) : 839-848. [pub] 20241025

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003800

Grantová podpora
22-33968S Czech Science Foundation

OBJECTIVE: This study aims to evaluate the efficacy of the Uniform Data Set (UDS) 2 battery in distinguishing between individuals with mild cognitive impairment (MCI) attributable to Alzheimer's disease (MCI-AD) and those with MCI due to other causes (MCI-nonAD), based on contemporary AT(N) biomarker criteria. Despite the implementation of the novel UDS 3 battery, the UDS 2 battery is still used in several non-English-speaking countries. METHODS: We employed a cross-sectional design. A total of 113 Czech participants with MCI underwent a comprehensive diagnostic assessment, including cerebrospinal fluid biomarker evaluation, resulting in two groups: 45 individuals with prodromal AD (A+T+) and 68 participants with non-Alzheimer's pathological changes or normal AD biomarkers (A-). Multivariable logistic regression analyses were employed with neuropsychological test scores and demographic variables as predictors and AD status as an outcome. Model 1 included UDS 2 scores that differed between AD and non-AD groups (Logical Memory delayed recall), Model 2 employed also Letter Fluency and Rey's Auditory Verbal Learning Test (RAVLT). The two models were compared using area under the receiver operating characteristic curves. We also created separate logistic regression models for each of the UDS 2 scores. RESULTS: Worse performance in delayed recall of Logical Memory significantly predicted the presence of positive AD biomarkers. In addition, the inclusion of Letter Fluency RAVLT into the model significantly enhanced its discriminative capacity. CONCLUSION: Our findings demonstrate that using Letter Fluency and RAVLT alongside the UDS 2 battery can enhance its potential for differential diagnostics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003800
003      
CZ-PrNML
005      
20250206104718.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/arclin/acae028 $2 doi
035    __
$a (PubMed)38582748
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Čihák, Martin $u Department of Neurology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000177654799
245    10
$a Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers / $c M. Čihák, H. Horáková, M. Vyhnálek, K. Veverová, V. Matušková, J. Laczó, J. Hort, T. Nikolai
520    9_
$a OBJECTIVE: This study aims to evaluate the efficacy of the Uniform Data Set (UDS) 2 battery in distinguishing between individuals with mild cognitive impairment (MCI) attributable to Alzheimer's disease (MCI-AD) and those with MCI due to other causes (MCI-nonAD), based on contemporary AT(N) biomarker criteria. Despite the implementation of the novel UDS 3 battery, the UDS 2 battery is still used in several non-English-speaking countries. METHODS: We employed a cross-sectional design. A total of 113 Czech participants with MCI underwent a comprehensive diagnostic assessment, including cerebrospinal fluid biomarker evaluation, resulting in two groups: 45 individuals with prodromal AD (A+T+) and 68 participants with non-Alzheimer's pathological changes or normal AD biomarkers (A-). Multivariable logistic regression analyses were employed with neuropsychological test scores and demographic variables as predictors and AD status as an outcome. Model 1 included UDS 2 scores that differed between AD and non-AD groups (Logical Memory delayed recall), Model 2 employed also Letter Fluency and Rey's Auditory Verbal Learning Test (RAVLT). The two models were compared using area under the receiver operating characteristic curves. We also created separate logistic regression models for each of the UDS 2 scores. RESULTS: Worse performance in delayed recall of Logical Memory significantly predicted the presence of positive AD biomarkers. In addition, the inclusion of Letter Fluency RAVLT into the model significantly enhanced its discriminative capacity. CONCLUSION: Our findings demonstrate that using Letter Fluency and RAVLT alongside the UDS 2 battery can enhance its potential for differential diagnostics.
650    _2
$a lidé $7 D006801
650    12
$a Alzheimerova nemoc $x diagnóza $x mozkomíšní mok $7 D000544
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a kognitivní dysfunkce $x diagnóza $x etiologie $7 D060825
650    12
$a neuropsychologické testy $x normy $x statistika a číselné údaje $7 D009483
650    12
$a biologické markery $x mozkomíšní mok $7 D015415
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a průřezové studie $7 D003430
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a proteiny tau $x mozkomíšní mok $7 D016875
650    _2
$a amyloidní beta-protein $x mozkomíšní mok $7 D016229
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horáková, Hana $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $u Department of Clinical Psychology, Motol University Hospital, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000341921423
700    1_
$a Vyhnálek, Martin $u Department of Neurology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000259764932 $7 xx0070891
700    1_
$a Veverová, Kateřina $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $u Department of Psychology, Faculty of Arts, Charles University, 116 38 Prague, Czech Republic $1 https://orcid.org/0000000258451854
700    1_
$a Matušková, Veronika $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000250331049
700    1_
$a Laczó, Jan $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000331862669
700    1_
$a Hort, Jakub $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000210803726
700    1_
$a Nikolai, Tomáš $u Department of Neurology, Second Faculty of Medicine and Motol University Hospital, Charles University, 150 06 Prague, Czech Republic $u Department of Clinical Psychology, Motol University Hospital, 150 06 Prague, Czech Republic $u Department of Psychology, Faculty of Arts, Charles University, 116 38 Prague, Czech Republic $1 https://orcid.org/0000000201047228 $7 mzk2008442770
773    0_
$w MED00008570 $t Archives of clinical neuropsychology $x 1873-5843 $g Roč. 39, č. 7 (2024), s. 839-848
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38582748 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104714 $b ABA008
999    __
$a ok $b bmc $g 2263525 $s 1239807
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 39 $c 7 $d 839-848 $e 20241025 $i 1873-5843 $m Archives of clinical neuropsychology $n Arch Clin Neuropsychol $x MED00008570
GRA    __
$a 22-33968S $p Czech Science Foundation
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace